Gelecek Etki VC
Esentepe, Büyükdere Street, Levent 199 No:199 Interior Door No:16 Şişli, Istanbul, Turkey
Overview
Future Impact Fund is a venture capital investment fund. It was established by Vestel Ventures and Tacirler Asset Management to provide financial support to startups.
- Total investments
- 8
- Lead investments
- 0
- Investments · 12mo
- 5
- Active investors
- 0
Investment portfolio
- Promake
Participated · Seed · Jun 2026
Promake offers an AI-driven platform designed to simplify and centralize digital operations for small businesses via a conversational interface that handles website setup, domain acquisition, corporate email, e-commerce infrastructure, payment integrations and digital advertising. The company launched its services globally in February and closed a $4 million financing round to support its next growth stage. Promake plans to use the new capital to reinforce its AI backbone, grow its team, expand into new geographic markets and develop additional end-to-end service layers covering business setup and management. Leadership frames the product as a digital team member that lets users perform tasks with natural language rather than complex management panels. Coverage names Emre Tekin as CEO and lists founders Eren, Evren and Dinçer as part of the founding team. Promake cites the global opportunity of serving hundreds of millions of small businesses as a long-term market objective.
- PhiTech Bioinformatics
Participated · Equity · Apr 2026
PhiTech operates a clinical decision-support platform called G&M (Genomik ve Dahası) that simultaneously analyzes patients’ DNA (genomic) and RNA (transcriptomic) sequencing data to produce actionable results for hospitals, genetic diagnostic laboratories and pharmaceutical companies. The platform aims to increase diagnostic yield in complex cases where DNA-only tests are insufficient, and the company reports that many previously undiagnosed patients in Turkey reached correct diagnoses using its system in the past year. PhiTech maintains its research and development center in Turkey and has offices in the United States and the Netherlands, while pursuing international patent applications for its software. With the newly raised $2.4 million, the company plans to broaden market adoption of its rare-disease solutions and finalize research programs for cancer-directed products. Founding scientific leaders include Dr. Saliha Durmuş, Prof. Dr. Tunahan Çakır and Prof. Dr. Erdoğan Sevilgen.
- Mindsite
Participated · Equity · Jan 2026
Founded in 2019, Mindsite provides infrastructure that aggregates data from more than 500 retailers across 20+ countries, turning those insights into actionable recommendations for e-commerce teams. Its toolkit already includes Masterdata Agent, Growth Agent and Review Sentiment Analysis, and the company is now building a new AI agent designed to automate decision-making and execute actions in the field. Enterprise customers such as Colgate, Unilever, Arçelik, Watsons, Migros and Eczacıbaşı use the platform to monitor and manage digital shelf operations. Mindsite currently operates offices in the United Kingdom and Indonesia and intends to open new locations in Malaysia, Australia, the United Arab Emirates, Saudi Arabia and Brazil. The team also plans to pursue strategic acquisitions to expand its product capabilities and regional reach. With the latest capital injection, the company will continue scaling its global organization and accelerate development of AI-agent-based products.
- Onlayer
Participated · Series A · Nov 2025
Onlayer offers a unified, AI-driven platform that automates merchant onboarding, continuously monitors merchant portfolios, and handles PCI-DSS compliance for financial institutions and enterprises. Its software combines merchant acquisition, real-time monitoring, anti-money-laundering (AML) and fraud controls, compliance workflows, and data-driven analytics in a single environment. The company’s solutions aim to help customers mitigate risk, meet regulatory requirements, and uncover growth opportunities. Headquartered in Ankara, it maintains offices in London, Dubai, and Saudi Arabia, and currently serves clients in 12 countries. Management plans to deploy new capital to expand further across the MENA and Asia-Pacific regions. The funding will also be used to enhance the platform’s AI-powered risk, compliance, and performance modules.
- Upsonic
Participated · Equity · Oct 2025
Turkey-based Upsonic has developed AgentOS, an open-source control layer that lets fintechs and banks create, monitor and scale AI agents to handle KYC, risk analysis, compliance reporting and fraud detection. The framework incorporates a Safety Engine, reliability-first design and multi-model support so developers can move projects into production with confidence. Beyond individual agents, the platform supplies governance and performance-tracking tooling, turning manual back-office processes into autonomous, auditable workflows. Upsonic positions itself at the center of the emerging agentic-AI stack, aiming to set industry standards rather than merely follow trends. While specific revenue or user figures were not disclosed, the company’s traction is evidenced by interest from local and international investors. The newly raised capital will be used to expand AgentOS globally and deepen its feature set for heavily regulated financial institutions.
Team
No current team members are available.